The fact that the association between GSTM1 CNV and bladder cancer can be detected with LRR values without applying a calling CNV confirms the utility of this measure as a complementary screening strategy to test for association at the genome-wide level, as already suggested [17-19]. Here, GSTM1 is linked to urinary bladder cancer.